|
| Status |
Public on Dec 19, 2008 |
| Title |
HB22 |
| Sample type |
RNA |
| |
|
| Source name |
Human Breast Tumor
|
| Organism |
Homo sapiens |
| Characteristics |
Label : pCR
Estrogen Receptor : Ep
Progesterone Receptor : Pp
Size: T2
Node: N1
|
| Treatment protocol |
none
|
| Extracted molecule |
total RNA |
| Extraction protocol |
Qiagen RNeasy Mini Kit
|
| Label |
biotin
|
| Label protocol |
standard Affymetrix procedure
|
| |
|
| Hybridization protocol |
Standard Affymetrix procedure
|
| Scan protocol |
Standard Affymetrix procedure
|
| Description |
Series of 102 tumours
|
| Data processing |
RMA
|
| |
|
| Submission date |
Oct 11, 2006 |
| Last update date |
Jun 06, 2022 |
| Contact name |
Mauro Delorenzi |
| E-mail(s) |
[email protected]
|
| Organization name |
Swiss Institute of Bioinformatics
|
| Lab |
BCF
|
| Street address |
Génopode Building, Quartier Sorge
|
| City |
Lausanne |
| ZIP/Postal code |
1015 |
| Country |
Switzerland |
| |
|
| Platform ID |
GPL1352 |
| Series (1) |
| GSE4779 |
A stroma-related gene signature predicts sensitivity to epirubicin-containing neoadjuvant chemotherapy in breast cancer. |
|
| Relations |
| Reanalyzed by |
GSE205568 |
